Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.
Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P; BMBF Competence Network "Inflammatory Bowel disease". Schreiber S, et al. Among authors: campieri m. Int J Colorectal Dis. 2001 Feb;16(1):1-11; discussion 12-3. doi: 10.1007/s003840100285. Int J Colorectal Dis. 2001. PMID: 11317691
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
Sandborn WJ, Löfberg R, Feagan BG, Hanauer SB, Campieri M, Greenberg GR. Sandborn WJ, et al. Among authors: campieri m. Am J Gastroenterol. 2005 Aug;100(8):1780-7. doi: 10.1111/j.1572-0241.2005.41992.x. Am J Gastroenterol. 2005. PMID: 16086715 Clinical Trial.
A phase II study of laquinimod in Crohn's disease.
D'Haens G, Sandborn WJ, Colombel JF, Rutgeerts P, Brown K, Barkay H, Sakov A, Haviv A, Feagan BG; Laquinimod for Crohn's Disease Investigators. D'Haens G, et al. Gut. 2015 Aug;64(8):1227-35. doi: 10.1136/gutjnl-2014-307118. Epub 2014 Oct 3. Gut. 2015. PMID: 25281416 Free PMC article. Clinical Trial.
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.
Kühbacher T, Ott SJ, Helwig U, Mimura T, Rizzello F, Kleessen B, Gionchetti P, Blaut M, Campieri M, Fölsch UR, Kamm MA, Schreiber S. Kühbacher T, et al. Among authors: campieri m. Gut. 2006 Jun;55(6):833-41. doi: 10.1136/gut.2005.078303. Epub 2006 Jan 9. Gut. 2006. PMID: 16401690 Free PMC article. Clinical Trial.
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.
Prantera C, Kohn A, Campieri M, Caprilli R, Cottone M, Pallone F, Savarino V, Sturniolo GC, Vecchi M, Ardia A, Bellinvia S. Prantera C, et al. Among authors: campieri m. Aliment Pharmacol Ther. 2009 Nov 1;30(9):908-18. doi: 10.1111/j.1365-2036.2009.04117.x. Epub 2009 Aug 12. Aliment Pharmacol Ther. 2009. PMID: 19678813 Free article. Clinical Trial.
Attachment and quality of life in patients with inflammatory bowel disease.
Agostini A, Moretti M, Calabrese C, Rizzello F, Gionchetti P, Ercolani M, Campieri M. Agostini A, et al. Among authors: campieri m. Int J Colorectal Dis. 2014 Oct;29(10):1291-6. doi: 10.1007/s00384-014-1962-3. Epub 2014 Jul 19. Int J Colorectal Dis. 2014. PMID: 25034592
214 results